About Brian Johnson
Brian Johnson is a chief executive officer and director at Caradon Therapeutics.
Form D filings also name Brian Johnson as an executive officer and director at Antlia Bioscience.
Brian Johnson first appears on SEC filings in 2020.
Experience
This experience comes from Brian Johnson's profile and from SEC filings. For roles taken from filings, the years are when the filings name Brian Johnson in the role, so the role may have started earlier or lasted longer.
Caradon Therapeutics, Inc. Current
Chief Executive Officer and director
Founder and Executive (2023 – Present)
2023 – Present · Encinitas, CA
Antlia Bioscience, Inc. Current
Founder & Executive Director (2020 – Present)
Director
2020 – Present · Encinitas, CA
Develops long-acting treatments for people with chronic heart and metabolic diseases.
IT
Inflamma Therapeutics
Co-Founder
2020 – 2022
HI
HUYA Bioscience International
Senior Vice President Global Human Resources
2019 – 2020
NU
NuVasive
Senior Director of Legal Affairs
2016 – 2019
AI
ABM Industries
Assistant General Counsel
2013 – 2016
JD
Jones Day
Senior Associate
2007 – 2013
PP
Pillsbury Winthrop Shaw Pittman
Attorney
2004 – 2007
PS
Pillsbury Madison & Sutro
Attorney
2001 – 2004
Key Colleagues at Startups
The people Brian Johnson works with at each company, as listed on that company's latest Form D.
Antlia Bioscience, Inc. · Form D, Jun 5, 2026
AM
Ankit Mahadevia
Chief Executive Officer and director
BA
Ben Auspitz
Director
MT
Martin Taylor
Director
CE
Carlos Echeverria
Director
NS
Nihal Sinha
Director